HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yubao Shao Selected Research

Neoplasms (Cancer)

10/2019Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yubao Shao Research Topics

Disease

3Rheumatoid Arthritis
05/2024 - 01/2022
2Interstitial Lung Diseases (Interstitial Lung Disease)
05/2024 - 12/2022
2Fibrosis (Cirrhosis)
05/2024 - 12/2022
2Inflammation (Inflammations)
05/2024 - 08/2023
1Arthritis (Polyarthritis)
05/2024
1Osteoarthritis
08/2023
1Wounds and Injuries (Trauma)
08/2023
1Experimental Arthritis
01/2023
1Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2022
1Neoplasms (Cancer)
10/2019
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2019

Drug/Important Bio-Agent (IBA)

3ResveratrolIBA
05/2024 - 01/2022
1Collagen Type II (Type II Collagen)IBA
05/2024
1Freund's AdjuvantIBA
05/2024
1Long Noncoding RNAIBA
08/2023
1AnisomycinIBA
08/2023
1p38 Mitogen-Activated Protein KinasesIBA
08/2023
1Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA
01/2023
1Ligases (Synthetase)IBA
10/2019
1Proteins (Proteins, Gene)FDA Link
10/2019
1bcr-abl Fusion ProteinsIBA
10/2019

Therapy/Procedure

1Surgical Amputation (Amputations)
08/2023